Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cynosure Inc (NASDAQ:CYNO)

52.14
Delayed Data
As of Jul 22
 +0.76 / +1.48%
Today’s Change
29.00
Today|||52-Week Range
53.33
+16.72%
Year-to-Date

Today’s Trading

Previous close51.38
Today’s open51.59
Day’s range51.26 - 52.57
Volume261,102
Average volume (3 months)333,190
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-50.35%
Earnings growth (this year)+19.14%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+16.11%
P/E ratio64.3
Price/Sales2.98
Price/Book2.93

Competitors

 Today’s
change
Today’s
% change
XLRNAcceleron Pharma Inc-0.02-0.06%
CNMDConmed Corp-0.28-0.58%
PTLAPortola Pharmaceutic...+0.27+1.13%
PCRXPacira Pharmaceutica...+0.71+1.89%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$0.29
Annual revenue (last year)$339.5M
Annual profit (last year)$15.8M
Net profit margin4.66%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Davin
Chief Operating &
Financial Officer
Timothy W. Baker
Corporate headquarters
Westford, Massachusetts

Forecasts

Partner Offers

Search for Jobs